Lilly’s Japan outlay comes on the heels of a major $3 billion investment in the company’s manufacturing operations in China, where the pharma giant has pledged to set up local production for oral ...

The pharmaceutical industry is engaging in a flurry of biotech deals and shifting clinical trials to China. It does so at a time when the U.S. is distancing from China.

Regulatory compliance adds a major layer of operational complexity. Pharmaceutical supply chains must comply with stringent ...

The two new facilities will create 300 jobs and are part of the drugmaker’s broader plan to invest $100 billion in the U.S.

CSL, a global pharmaceutical manufacturer based in Melbourne, Australia, has broken ground on a $1.5 billion expansion of its campus in Kankakee, roughly 60 miles southwest of Chicago. The company has ...

INCREASING investments and efforts to expand local drug manufacturing will drive the Philippine pharmaceutical market to grow to P759 billion ($12.1 billion) by 2030, BMI, a unit of Fitch Solutions, ...

Virginia attracted $12 billion in pharmaceutical manufacturing investments in 2025, leveraging site readiness, workforce training, and strong infrastructure.

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today’s Pharmaceutical Executive Daily, ...

This article explores current OSD development and manufacturing trends from a CDMO perspective, including the evolution of ...

At long last, the Trump administration’s much-ballyhooed tariffs on pharmaceutical imports are materializing in a trade deal with the European Union. Still, as with previous communications on the ...

In the opening remarks, Michael Kopcha, Director of the Office of Pharmaceutical Quality (OPQ), offered CDER’s perspective on advanced manufacturing and pharmaceutical quality. He began the ...

Corden Pharma Colorado Inc., a developer and manufacturer of peptide drug substances, has leased the 64,000-square-foot 5505 ...